On this episode of "This Changes Things" we speak to the founder of Tibi about the challenges she faced launching the company while living abroad in Hong Kong. She shares her beset advice for breaking the language barrier.
Our round table takes a look at how managers can handle workplace issues ranging from office relationships to harassment. Liz Bentley, President of Liz Bentley Associates, and Emily Anne Epstein, Executive News Editor at Bustle, outline the difference between what's appropriate and what's not in the office.
Plus, tech reporter Jared Lindzon shares some of the most common ways cyber attackers take advantage of online shoppers during the holidays. Tune in for his top tips for protecting your data and your wallet.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
